- Home
- NSA vs EWTX Comparison
NSA vs EWTX Comparison
Compare NSA & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSA | EWTX |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | 1466 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.3B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NSA | EWTX |
|---|---|---|
| Price | $34.67 | $29.91 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $32.63 | ★ $34.71 |
| AVG Volume (30 Days) | ★ 1.3M | 691.3K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | ★ 6.64% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.41 | N/A |
| P/E Ratio | $56.31 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.43 | $10.60 |
| 52 Week High | $40.61 | $31.82 |
Technical Indicators
Market Signals| Indicator | NSA | EWTX |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 54.85 |
| Support Level | $31.20 | $13.56 |
| Resistance Level | N/A | $30.77 |
| Average True Range (ATR) | 0.94 | 1.49 |
| MACD | 0.03 | -0.16 |
| Stochastic Oscillator | 61.10 | 52.72 |
Price Performance
Historical ComparisonAbout NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.